RecruitingPhase 3NCT07535749

The Effect of Myopia-Control Contact Lenses in New Zealand Chinese Children

Sponsor

Aston University

Enrollment

66 participants

Start Date

Mar 21, 2026

Study Type

INTERVENTIONAL

Conditions

Myopia Progression

Summary

The study will employ a randomized, controlled, investigator-masked paired-eye comparison design to evaluate the effects of two myopia-control contact lenses-MiSight 1 Day and Abiliti 1-Day-in New Zealand Chinese children. The study duration will be 6 months, with assessments conducted at baseline, 2 weeks, 3 months, and 6 months. The clinical research will be conducted at the Auckland Myopia Clinic (New Zealand) and will follow a standard clinical routine for children with early myopia, the only difference being the randomizing of the MiSight and Abiliti contact lenses between the two eyes of the participants.

Eligibility

Min Age: 7 YearsMax Age: 11 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Albiliti 1-Day (Johnson and Johnson, VisionCare) and a medical device called MiSight Contact Lenses (CooperVision) for people with myopia progression. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.